Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast episode artwork

EPISODE · Jul 7, 2022 · 16 MIN

Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast

from Stock Day Media · host Stock Day Media

The Stock Day Podcast welcomed Acasti Pharma Inc. (ACST)(“the Company”), a specialty pharma company with drug delivery technologies and novel drug candidates addressing rare and orphan diseases. CEO of the Company, Jan D’Alvise, joined Stock Day host Sever Copley.  Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode metadata supplied by the publisher feed · Published Jul 7, 2022

Embed this episode

NOW PLAYING

Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast

0:00 16:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Stock Day Media?

This episode is 16 minutes long.

When was this Stock Day Media episode published?

This episode was published on July 7, 2022.

Can I download this Stock Day Media episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!